143 related articles for article (PubMed ID: 36634277)
21. Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events: A Systematic Review and Meta-analysis.
Farooq MZ; Aqeel SB; Lingamaneni P; Pichardo RC; Jawed A; Khalid S; Banskota SU; Fu P; Mangla A
JAMA Netw Open; 2022 Apr; 5(4):e227722. PubMed ID: 35438755
[TBL] [Abstract][Full Text] [Related]
22. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies.
Bander ED; Yuan M; Carnevale JA; Reiner AS; Panageas KS; Postow MA; Tabar V; Moss NS
Cancer; 2021 Jun; 127(12):2062-2073. PubMed ID: 33651913
[TBL] [Abstract][Full Text] [Related]
23. Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non-small-cell Lung Cancer Brain Metastases.
Enright TL; Witt JS; Burr AR; Yadav P; Leal T; Baschnagel AM
Clin Lung Cancer; 2021 Mar; 22(2):110-119. PubMed ID: 33281062
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability.
Backlund E; Grozman V; Egyhazi Brage S; Lewensohn R; Lindberg K; Helgadottir H
Acta Oncol; 2023 Dec; 62(12):1921-1930. PubMed ID: 37966921
[TBL] [Abstract][Full Text] [Related]
25. Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
Franklin C; Mohr P; Bluhm L; Grimmelmann I; Gutzmer R; Meier F; Garzarolli M; Weichenthal M; Pfoehler C; Herbst R; Terheyden P; Utikal J; Ulrich J; Debus D; Haferkamp S; Kaatz M; Forschner A; Leiter U; Nashan D; Kreuter A; Sachse M; Welzel J; Heinzerling L; Meiss F; Weishaupt C; Gambichler T; Weyandt G; Dippel E; Schatton K; Celik E; Trommer M; Helfrich I; Roesch A; Zimmer L; Livingstone E; Schadendorf D; Horn S; Ugurel S
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688555
[TBL] [Abstract][Full Text] [Related]
26. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer.
Wang SJ; Khullar K; Kim S; Yegya-Raman N; Malhotra J; Groisberg R; Crayton SH; Silk AW; Nosher JL; Gentile MA; Mehnert JM; Jabbour SK
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33020239
[TBL] [Abstract][Full Text] [Related]
27. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis.
Su Z; Zhang L; Xue S; Wang Y; Ding R
Open Life Sci; 2023; 18(1):20220559. PubMed ID: 36874630
[TBL] [Abstract][Full Text] [Related]
28. A single-center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan.
Wada S; Ogata D; Kashihara T; Okuma K; Eto H; Nakano E; Takahashi A; Namikawa K; Igaki H; Yamazaki N
Cancer Med; 2023 Dec; 12(24):21933-21943. PubMed ID: 38083908
[TBL] [Abstract][Full Text] [Related]
29. Combination of radiotherapy and immunotherapy for brain metastases: A systematic review and meta-analysis.
Petrelli F; De Stefani A; Trevisan F; Parati C; Inno A; Merelli B; Ghidini M; Bruschieri L; Vitali E; Cabiddu M; Borgonovo K; Ghilardi M; Barni S; Ghidini A
Crit Rev Oncol Hematol; 2019 Dec; 144():102830. PubMed ID: 31733443
[TBL] [Abstract][Full Text] [Related]
30. State of the Art in Combination Immuno/Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis.
Najafi M; Jahanbakhshi A; Gomar M; Iotti C; Giaccherini L; Rezaie O; Cavallieri F; Deantonio L; Bardoscia L; Botti A; Sardaro A; Cozzi S; Ciammella P
Curr Oncol; 2022 Apr; 29(5):2995-3012. PubMed ID: 35621634
[TBL] [Abstract][Full Text] [Related]
31. Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy.
Guan H; Zhou Z; Hou X; Zhang F; Zhao J; Hu K
Asia Pac J Clin Oncol; 2023 Feb; 19(1):35-50. PubMed ID: 35538049
[TBL] [Abstract][Full Text] [Related]
32. Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases.
Jiang C; Kleber TJ; Switchenko JM; Khan MK
Radiat Oncol; 2021 Feb; 16(1):31. PubMed ID: 33557890
[TBL] [Abstract][Full Text] [Related]
33. External beam radiation dose escalation for high grade glioma.
Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
[TBL] [Abstract][Full Text] [Related]
34. Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis.
Lu VM; Goyal A; Rovin RA; Lee A; McDonald KL
J Neurooncol; 2019 Jan; 141(1):1-12. PubMed ID: 30392086
[TBL] [Abstract][Full Text] [Related]
35. Combination of radiation and immunotherapy in the treatment of genitourinary malignancies: A systematic review and meta-analysis.
Maisch P; Koll F; Bolenz C; Chun FK; Gschwend JE; Schmid SC
Urol Oncol; 2023 May; 41(5):219-232. PubMed ID: 36372634
[TBL] [Abstract][Full Text] [Related]
36. Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practice.
Jablonska PA; Fong CH; Kruser T; Weiss J; Liu ZA; Takami H; Narita Y; Ynoe de Moraes F; Dasgupta A; Ong CK; Yang JCH; Lee JH; Pavlakis N; Kongkham P; Butler M; Shultz DB
Radiother Oncol; 2022 Mar; 168():89-94. PubMed ID: 35121033
[TBL] [Abstract][Full Text] [Related]
37. Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.
Zhao Q; Qin Q; Sun J; Han D; Wang Z; Teng J; Li B
PLoS One; 2016; 11(3):e0150419. PubMed ID: 26930609
[TBL] [Abstract][Full Text] [Related]
38. Combination of Immune Checkpoint Inhibitors and Radiotherapy for Advanced Non-Small-Cell Lung Cancer and Prostate Cancer: A Meta-Analysis.
Xu Z; Feng J; Weng Y; Jin Y; Peng M
J Oncol; 2021; 2021():6631643. PubMed ID: 33488711
[TBL] [Abstract][Full Text] [Related]
39. Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases.
Moyers JT; Chong EG; Peng J; Tsai HHC; Sufficool D; Shavlik D; Nagaraj G
Cancer Med; 2021 Feb; 10(4):1201-1211. PubMed ID: 33484100
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]